The 2021 Centers for Medicare and Medicaid Services Fee Schedule’s Impact on Adult Reconstruction Surgeon Productivity and Reimbursement

• Published in: The Journal of arthroplasty 2021-10, Vol.36 (10), p.3381-3387
• Main Authors: Skeehan, Christopher D., Ortiz, Dionisio, Sicat, Chelsea Sue, Iorio, Richard, Slover, James, Bosco, Joseph A.
• Format: Article
• Language: English
• Subjects: CMS fee schedule; productivity; reimbursement; total joint replacements; work relative value units
• ISSN: 0883-5403; 1532-8406
• DOI: 10.1016/j.arth.2021.06.004

On December 20, 2020, the Centers for Medicare and Medicaid Services (CMS) finalized its proposed rule: CMS-1734-P. This 2021 Final Rule significantly changed Medicare total joint arthroplasty (TJA) reimbursement. The precise impact on surgeon productivity and reimbursement is unknown. In the present study, we sought to model the potential impact of these changes for multiple unique practice configurations. A mathematical model was applied to CMS data to determine the impact of CMS-1734-F on multiple, theoretical TJA practice configurations. Variables tested were the annual percentage of revision vs primary arthroplasty cases performed and the annual percentage of operative vs office-based productivity. The model defined baseline annual surgeon productivity as the 2018 Medical Group Management Association hip and knee arthroplasty surgeon median productivity of 10,568 work relative value units (wRVUs). All modeled simulations demonstrated a year-to-year increase in wRVUs independent of practice configuration. However, simulations that demonstrated less than a 3.35% increase in wRVUs from year-to-year saw a decrease in reimbursement. Those simulations with higher wRVU increases tended to have a higher percentage of revision vs primary arthroplasty cases and/or had annual productivity that was derived to a greater extent from office encounters than surgical cases. The impact of CMS-1734-F will vary based on 3 factors: (1) the relative contribution of a surgeon’s operative TJA practice compared with their office-based practice to their annual wRVUs; (2) the relative percentage of revision TJAs vs the percentage of primary TJAs performed; and (3) the relative percentage of primary TJA compared to non-arthroplasty surgeries as a component of overall operative practice. The decreased reimbursement will be disproportionately felt by arthroplasty surgeons who perform relatively fewer revision TJA procedures and whose office-based productivity makes up a smaller overall percentage of their annual workload.